Support care for patients recovering from pelvic gynecological cancers
Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase
This study is testing a new support program for women recovering from ovarian or endometrial cancer to see if it helps improve their quality of life after treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 99 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Centre Francois Baclesse Academic / other |
| Locations | 1 site (Caen) |
| Trial ID | NCT05731661 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the supportive care needs of patients who have completed treatment for ovarian or endometrial cancer. It involves day hospitalization where patients meet with support care professionals and receive personalized post-cancer care plans. The goal is to improve the organization of supportive oncology care and enhance the long-term quality of life for these patients. By assessing the complexity of care actions needed, the study seeks to provide tailored follow-up for cancer survivors.
Who should consider this trial
Good fit: Ideal candidates are women over 18 years old who are in complete remission after first-line treatment for endometrial or ovarian cancer.
Not a fit: Patients with locoregional or metastatic recurrence or those with significant medical or psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life for patients recovering from pelvic gynecological cancers.
How similar studies have performed: While supportive care in oncology is a recognized field, this specific approach to personalized post-cancer care is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient \> 18 years old * Patient in complete remission after first-line treatment for endometrial or ovarian/fallopian tube/peritoneal cancer * Patient having completed her initial treatment; patients with maintenance treatments are eligible * Mastery of the French language * Patient with a telephone line * Patient affiliated to a social security scheme * Signature of informed consent before any specific procedure related to the study Exclusion Criteria: * Any associated medical or psychiatric conditions that could compromise the patient's ability to participate in the study * Patient with locoregional or metastatic recurrence * Patient deprived of liberty, under guardianship or curatorship * Simultaneous participation in a therapeutic clinical trial
Where this trial is running
Caen
- Centre Francois Baclesse — Caen, France (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.